KN earnings call summary

Prepared Highlights

• Total Q1 revenue: $153M, +16% YoY, at the high end of guidance (prepared).
• Medtech & Specialty Audio (MSA) revenue: $68M, +14% YoY, driven by hearing health new product introductions (CEO).
• Precision Devices (PD) revenue: $85M, +17% YoY, with growth across Medtech, Defense, Industrial, and Electrification (CEO).
• MSA gross margin: 53.5%, up 480 bps YoY, due to higher factory utilization and favorable mix (CFO).
• PD gross margin: 39.2%, up 350 bps YoY, partially offset by ramp-up costs in specialty film line for a >$75M energy order (CFO).
• Total company gross margin: 53.5% (MSA) and 39.2% (PD) segments stated; total not explicitly given.
• Adjusted EPS: $0.27, +50% YoY, above the high end of guidance (prepared).
• Cash used in operations: $1M, within guidance; includes $8M in CMM business outflows (CFO).
• Capital spending: $11M in Q1; full-year expected ~4%–5% of revenue (CFO).
• PD book-to-bill: 1.19, sixth consecutive quarter >1.0, broad-based across all end markets (CEO).
• Backlog & orders: Robust backlog; PD order strength in Q1 across OEMs and distributors (CEO, CFO).
• Share repurchases: 276,000 shares at $7.5M in Q1 (CFO).
• Leverage: Net leverage ratio 0.6x; liquidity >$310M (cash + revolver capacity) (CFO).

Official Guidance (Q2 2026):

• Revenue: $152M–$162M, +8% YoY at midpoint (CFO).
• Adjusted EBIT margin: 20%–22% (CFO).
• EPS: $0.28–$0.32 per share, +25% YoY at midpoint (CFO).
• Cash from operations: $20M–$30M (CFO).
• Capital spending: $8M (CFO).

Full-Year 2026 Outlook:

• MSA revenue growth expected within 2%–4% organic annual target (CEO).
• PD revenue growth expected above 6%–8% organic target; total company growth above 4%–6% target (CEO, CFO).
• Adjusted EBITDA growth above 10%–14% cumulative annual target (CFO).

Mgmt Quotes:

• "We started 2026 with solid financial results in Q1 and great momentum entering the rest of the year." (CEO)
• "Our strategy of leveraging our unique technologies to design custom-engineered solutions... is proving to be a powerful combination." (CEO)
• "We saw strength in the defense market across our product families... capacitors were in demand supporting ongoing OEM investments." (CEO)
• "We are now expecting our revenue growth in 2026 to be above the high end of our target organic revenue target of 4% to 6%." (CEO)
• "Our first quarter performance, combined with a robust backlog and increased order activity... give me confidence in our ability to deliver an increase in 2026 adjusted EBITDA above our cumulative annual growth target of 10% to 14%." (CFO)

Prepared Metrics

Q&A Batch (1-4 of 4)

Q1 — Christopher Rolland

• Topic: 设计赢单分布与毛利率扩张驱动因素
• Key points:
  • 能源订单将在Q2末全面爬坡，Q1尚未显著贡献；国防订单上升，预计2026年强于预期，2027年表现更好。
  • PD业务定价每年可提升2%–4%；MSA业务毛利率预期全年持平于51%（Q1因满产和产品组合略高）。
  • PD部门Q1毛利率39.1%，Q2维持该水平，后半年随特种薄膜线、陶瓷电容及RF滤波器产能利用率提升有望显著改善。
• Mgmt stance: 看涨——广泛的需求基础、定价能力及产能爬坡将驱动毛利率上行。

Q2 — Will Gildea

• Topic: 特种薄膜试点进展与国防相关成本影响
• Key points:
  • 未来一季将向约20个不同客户交付试点；能源订单在产量和良率上均按计划推进，预计下半年贡献超2500万美元收入且毛利率良好。
  • PD部门全年毛利率预计同比提升100个基点，主要由下半年驱动。
  • 战争影响主要限于树脂等原材料小幅上涨，运输成本因多数客户自提而影响极小。
• Mgmt stance: 看涨——试点进展顺利，能源订单成熟，通胀影响有限。

Q3 — Anthony Stoss

• Topic: 定价能力、2027毛利率展望、能源订单爬坡与RF卫星业务
• Key points:
  • PD定价每年2%–4%，可能朝区间上沿移动；2027年毛利率有望高于2026年，因2026年毛利率持续改善。
  • 能源订单所有设备已到位，Q1产出略超预期，无重大技术障碍，属常规爬坡。
  • RF卫星业务存在但聚焦高频高性能非标产品，避免商品化；RF部门Q1实现两位数同比增长。
• Mgmt stance: 中性偏看涨——定价策略稳健，能源订单进展良好，RF增长但坚持差异化。

Q4 — Tristan Gerra

• Topic: PD产能利用率、能源订单对毛利率的影响及客户长期订单趋势
• Key points:
  • PD整体产能利用率约80%，未来扩产主要需增加直接人力，无需大量资本开支；能源订单当前压制PD毛利率，但后半年将带动该部门毛利率提升200–250个基点。
  • 国防客户开始寻求3–5年长期订单，但当前1.19的book-to-bill中97%将在12个月内出货，无异常大单。
• Mgmt stance: 看涨——产能有提升空间，能源订单将成为下半年利润率改善的核心驱动，长期订单讨论增加表明需求强劲。